Biotechnology / Pharmaceuticals
€ 105 8.1
Share price
$ 22 bn
Market Cap
$ 23 bn
Enterprise Value

Carbon footprint

2 Ton
GHG emissions per $ 1 mln investment
0.06x the weighted average for S&P 500
How is this calculated?
YOY change in GHG emissions
Weaker than the -11% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

UCB aims to reduce all Scopes by 38% by 2030 from a base year 2015


GHG emissions and Carbon intensity

UCB's GHG emissions (location-based) (Kt of CO2e)
UCB's Carbon intensity (Tons per 1 USDm)

UCB's carbon footprint

UCB reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 46 Kt (-2.5 /-5.2% y-o-y). Also positively, carbon intensity declined to 7.1 t (-1.1 /-13.4% y-o-y).

UCB's Scope 3 emissions decreased to 34 Kt (-4.2 /-11% y-o-y). The rate of decline has slowed vs. the previous periods (CAGR -17% since 4Q'15).

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Company environmental metrics

Show more...